Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.

view more →

AtaCor Medical is developing a novel extracardiac pacing system that does not require leads or hardware to be placed inside or onto the heart.

view more →

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

view more →

Boomerang Medical is developing a technology to advance the treatment of autoimmune diseases by using electrical nerve stimulation

view more →

Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI

view more →

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into one single catheter.

view more →

CVRx has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. IPO in June 2021 (NASDAQ: CVRX).

view more →

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

view more →

Developer of a system to enhance embolic cerebral protection. Acquired by Edwards Lifesciences (NYSE: EW) in March 2011.

view more →

Endogenex is a clinical stage company, founded to improve outcomes for people living with Type 2 Diabetes.

view more →

Developer of biologic and medical device technologies for wound management designed to improve the safety and availability of human blood supply.

view more →

GoCheck Kids is the leading digital vision screening platform for children. 

view more →

Provider of a histotripsy platform designed for the treatment of cancer. Acquired by Bezos Expeditions, Wellington K5 Global 2025

view more →

iVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

view more →

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

view more →

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke.

view more →

Standard Bariatrics is developing a clamp and stapler to standardize sleeve gastrectomy procedures. Acquired by Teleflex in September 2022.

view more →

Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.

view more →

Sleep management platform built to address sleep conditions from testing through ongoing care via a wearable patch

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910